6C7F image
Entry Detail
PDB ID:
6C7F
Keywords:
Title:
Crystal structure of human phosphodiesterase 2A with 1-(2-chloro-5-isobutoxy-phenyl)-N,4-dimethyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2018-01-22
Release Date:
2018-08-15
Method Details:
Experimental Method:
Resolution:
1.82 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:cGMP-dependent 3',5'-cyclic phosphodiesterase
Chain IDs:A, B, C
Chain Length:342
Number of Molecules:3
Biological Source:Homo sapiens
Primary Citation
Mathematical and Structural Characterization of Strong Nonadditive Structure-Activity Relationship Caused by Protein Conformational Changes.
J. Med. Chem. 61 7754 7766 (2018)
PMID: 30070482 DOI: 10.1021/acs.jmedchem.8b00713

Abstact

In medicinal chemistry, accurate prediction of additivity-based structure-activity relationship (SAR) analysis rests on three assumptions: (1) a consistent binding pose of the central scaffold, (2) no interaction between the R group substituents, and (3) a relatively rigid binding pocket in which the R group substituents act independently. Previously, examples of nonadditive SAR have been documented in systems that deviate from the first two assumptions. Local protein structural change upon ligand binding, through induced fit or conformational selection, although a well-known phenomenon that invalidates the third assumption, has not been linked to nonadditive SAR conclusively. Here, for the first time, we present clear structural evidence that the formation of a hydrophobic pocket upon ligand binding in PDE2 catalytic site reduces the size of another distinct subpocket and contributes to strong nonadditive SAR between two otherwise distant R groups.

Legend

Protein

Chemical

Disease

Primary Citation of related structures